Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Erythromycin breath test.
Rivory LP, Watkins PB. Rivory LP, et al. Clin Pharmacol Ther. 2001 Oct;70(4):395-9. Clin Pharmacol Ther. 2001. PMID: 11673756 No abstract available.
Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype.
Gurney H, Wong M, Balleine RL, Rivory LP, McLachlan AJ, Hoskins JM, Wilcken N, Clarke CL, Mann GJ, Collins M, Delforce SE, Lynch K, Schran H. Gurney H, et al. Among authors: rivory lp. Clin Pharmacol Ther. 2007 Jul;82(1):33-40. doi: 10.1038/sj.clpt.6100201. Epub 2007 May 9. Clin Pharmacol Ther. 2007. PMID: 17495881 Clinical Trial.
The erythromycin breath test for the prediction of drug clearance.
Rivory LP, Slaviero KA, Hoskins JM, Clarke SJ. Rivory LP, et al. Clin Pharmacokinet. 2001;40(3):151-8. doi: 10.2165/00003088-200140030-00001. Clin Pharmacokinet. 2001. PMID: 11327195 Review.
Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance.
Rivory LP, Qin H, Clarke SJ, Eris J, Duggin G, Ray E, Trent RJ, Bishop JF. Rivory LP, et al. Eur J Clin Pharmacol. 2000 Aug;56(5):395-8. doi: 10.1007/s002280000166. Eur J Clin Pharmacol. 2000. PMID: 11009048
Optimizing the erythromycin breath test for use in cancer patients.
Rivory LP, Slaviero K, Seale JP, Hoskins JM, Boyer M, Beale PJ, Millward MJ, Bishop JF, Clarke SJ. Rivory LP, et al. Clin Cancer Res. 2000 Sep;6(9):3480-5. Clin Cancer Res. 2000. PMID: 10999732 Clinical Trial.
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.
Sharma R, Hoskins JM, Rivory LP, Zucknick M, London R, Liddle C, Clarke SJ. Sharma R, et al. Among authors: rivory lp. Clin Cancer Res. 2008 Feb 1;14(3):817-25. doi: 10.1158/1078-0432.CCR-07-0425. Clin Cancer Res. 2008. PMID: 18245544 Free article.
Factors affecting cytochrome P-450 3A activity in cancer patients.
Baker SD, van Schaik RH, Rivory LP, Ten Tije AJ, Dinh K, Graveland WJ, Schenk PW, Charles KA, Clarke SJ, Carducci MA, McGuire WP, Dawkins F, Gelderblom H, Verweij J, Sparreboom A. Baker SD, et al. Among authors: rivory lp. Clin Cancer Res. 2004 Dec 15;10(24):8341-50. doi: 10.1158/1078-0432.CCR-04-1371. Clin Cancer Res. 2004. PMID: 15623611
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.
Wong M, Balleine RL, Blair EY, McLachlan AJ, Ackland SP, Garg MB, Evans S, Farlow D, Collins M, Rivory LP, Hoskins JM, Mann GJ, Clarke CL, Gurney H. Wong M, et al. Among authors: rivory lp. J Clin Oncol. 2006 Jun 1;24(16):2448-55. doi: 10.1200/JCO.2005.02.1295. Epub 2006 May 1. J Clin Oncol. 2006. PMID: 16651648
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy.
Slaviero KA, Clarke SJ, Rivory LP. Slaviero KA, et al. Among authors: rivory lp. Lancet Oncol. 2003 Apr;4(4):224-32. doi: 10.1016/s1470-2045(03)01034-9. Lancet Oncol. 2003. PMID: 12681266 Review.
The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.
Le Couteur DG, Fraser R, Hilmer S, Rivory LP, McLean AJ. Le Couteur DG, et al. Among authors: rivory lp. Clin Pharmacokinet. 2005;44(2):187-200. doi: 10.2165/00003088-200544020-00004. Clin Pharmacokinet. 2005. PMID: 15656697 Review.
73 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page